Direktorat Registrasi ObatValid

OMEPRAZOLE

BPOM Number: GKL1106506403A1
Approved: 16 March 2026
Expiry: 11 October 2028
Form: KAPSUL LEPAS TUNDA

About This Registration

OMEPRAZOLE is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL1106506403A1. Its current registration status is Valid, with the licence valid until 11 October 2028. The product is registered to ERRITA PHARMA and manufactured by ERRITA PHARMA - INDONESIA. BPOM first approved this registration in February 2026. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration data updated by BPOM

This product's registration details were changed on 13 November 2025. This may reflect a status change, renewal, or correction by BPOM.

Registration Details

Application: newaero
Packaging: DUS, 10 STRIP @ 10 KAPSUL LEPAS TUNDA
Department: Direktorat Registrasi Obat
Data Last Updated: 13 November 2025

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available

Custom questionnaires

Professional shoppers

Detailed reporting

Starting from $50 per city

What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

ERRITA PHARMA
Jl. Peundeuy RT. 04/07 Desa Bojongsalam, Kec. Rancaekek, Jawa Barat, Indonesia
NPWP: 011041811441000
owner
View profile →

Manufacturing Sites

ERRITA PHARMA - INDONESIA
KAB. BANDUNG
primary
View profile →

Ingredients (1)

OMEPRAZOLE PELLET

Market Intelligence

Owner Portfolio: ERRITA PHARMA holds 132 BPOM registrations
Manufacturer Scale: ERRITA PHARMA - INDONESIA produces 116 registered products
Registration Age: Registered for 7 months

FDA Cross-Reference

via openFDA

Generic Name: OMEPRAZOLE
Product Type: HUMAN OTC DRUG
Route of Administration: ORAL
Purpose: Purpose Acid reducer

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?